Bernstein cuts Advantest stock rating to Market Perform, slashes target

Published 24/03/2025, 06:38
Bernstein cuts Advantest stock rating to Market Perform, slashes target

On Monday, Bernstein analysts adjusted their stance on Advantest Corp (6857:JP) (OTC: ATEYY), a leading provider of testing equipment for the semiconductor industry with a market capitalization of $39.45 billion. According to InvestingPro data, the company currently trades at a high P/E ratio of 43.59 and appears slightly overvalued based on Fair Value analysis. The firm downgraded the stock rating from Outperform to Market Perform and significantly reduced the price target to JPY7,940.00 from the previous JPY12,400.00. This revision comes amidst revised earnings per share (EPS) estimates for the second to fourth quarter of the fiscal year ending March 2026.

Bernstein’s analysts have decreased their EPS forecasts for the upcoming quarters by approximately 15%, positioning their expectations around 10% below the consensus. The new price target is based on a 26 times multiple of the 12-month forward projected earnings per share, which aligns with the historical average for the company. The analysts have cited a preference for a neutral position as market expectations undergo a period of adjustment.

The report suggests that potential catalysts for a more positive outlook on Advantest may emerge towards the end of the year. This optimism is tied to anticipated demand from Rubin and Application-Specific Integrated Circuit (ASIC) for the year 2026. Despite the near-term revisions, Bernstein maintains a 12% growth rate forecast for Advantest’s fiscal year ending March 2027. For deeper insights into Advantest’s growth prospects and comprehensive financial analysis, investors can access the detailed Pro Research Report available on InvestingPro.

The analysts have also indicated that a constructive stance could be adopted earlier if market expectations are reset ahead of schedule, potentially triggered by a lower-than-anticipated full-year guidance. This approach reflects a wait-and-see attitude towards Advantest’s performance and market position in the coming months.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.